These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 1915651)
21. [Pathogenesis and management of Grave's ophthalmopathy]. Wierzbowska J; Stankiewicz A Klin Oczna; 2002; 104(2):147-53. PubMed ID: 12174459 [TBL] [Abstract][Full Text] [Related]
22. [Graves-Basedow ophthalmopathy in light of current views]. Mirkiewicz-Sieradzka B; Pacura M Przegl Lek; 2000; 57(6):307-12. PubMed ID: 11107861 [TBL] [Abstract][Full Text] [Related]
23. Graves' ophthalmopathy. Bistriceanu M; Cergă A; Lichiardopol-Răducanu C Oftalmologia; 1993; 37(2):99-103. PubMed ID: 8507632 [TBL] [Abstract][Full Text] [Related]
24. Association of HLA antigen BW35 with severe Graves' ophthalmopathy. Sergott RC; Felberg NT; Savino PJ; Blizzard JJ; Schatz NJ; Sanford CA Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):124-7. PubMed ID: 6600737 [TBL] [Abstract][Full Text] [Related]
25. [Pharma-clinics. How I treat ... thyroid ophthalmopathy]. Joachim M; Andris C; Duchesne B Rev Med Liege; 1996 Jul; 51(7):449-52. PubMed ID: 8766533 [No Abstract] [Full Text] [Related]
26. [Immunologic analysis of Graves' ophthalmopathy and ophthalmic Graves' disease]. Liao ZQ Zhonghua Yan Ke Za Zhi; 1990 May; 26(3):162-4. PubMed ID: 2144488 [TBL] [Abstract][Full Text] [Related]
27. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy. Wakelkamp IM; Prummel MF; Wiersinga WM Horm Metab Res; 2004 Jan; 36(1):44-7. PubMed ID: 14983406 [TBL] [Abstract][Full Text] [Related]
28. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908 [TBL] [Abstract][Full Text] [Related]
29. Peripheral parameters of oxidative stress in patients with infiltrative Graves' ophthalmopathy treated with corticosteroids. Bednarek J; Wysocki H; Sowiński J Immunol Lett; 2004 May; 93(2-3):227-32. PubMed ID: 15158621 [TBL] [Abstract][Full Text] [Related]
34. Current medical management of Graves ophthalmopathy. Marcocci C; Bartalena L; Marinò M; Rocchi R; Mazzi B; Menconi F; Morabito E; Pinchera A Ophthalmic Plast Reconstr Surg; 2002 Nov; 18(6):402-8. PubMed ID: 12439051 [No Abstract] [Full Text] [Related]
35. Long-term follow-up of patients with Graves' orbitopathy treated by plasmapheresis and immunosuppression. Zielinski CC; Weissel M; Müller C; Till P; Höfer R Dev Ophthalmol; 1989; 20():130-8. PubMed ID: 2574116 [No Abstract] [Full Text] [Related]
37. [Graves-Basedow ophthalmopathy]. Musch W Rev Med Brux; 2001 Jun; 22(3):A182-3. PubMed ID: 11488088 [No Abstract] [Full Text] [Related]
38. [Clinical study on therapeutic plasmapheresis--mechanism of its efficacy, indications, and the clinical application. j. Endocrine diseases]. Kishino B; Kikkawa T; Fushimi H Nihon Rinsho; 1984 Aug; 42(8):1905-7. PubMed ID: 6549031 [No Abstract] [Full Text] [Related]